Cromolyn Sodium Solution

Cromolyn Sodium Solution Manufacturers

• Actavis Mid Atlantic Llc
  

  ×

  Cromolyn Sodium Solution | Actavis Mid Atlantic Llc

  

  ---

  For management of bronchial asthma in adults and pediatric patients (two years of age and over), the usual starting dosage is the contents of one ampule administered by nebulization four times a day at regular intervals.

  Drug stability and safety of cromolyn sodium when mixed with other drugs in a nebulizer have not been established.

  Patients with chronic asthma should be advised that the effect of cromolyn sodium inhalation solution therapy is dependent upon its administration at regular intervals, as directed. Cromolyn sodium inhalation solution should be introduced into the patient’s therapeutic regimen when the acute episode has been controlled, the airway has been cleared and the patient is able to inhale adequately.

  For the prevention of acute bronchospasm which follows exercise or exposure to cold dry air, environmental agents (e.g., animal danders, toluene diisocyanate, pollutants), etc., the usual dose is the contents of one ampule administered by nebulization shortly before exposure to the precipitating factor.

  It should be emphasized to the patient that the drug is poorly absorbed when swallowed and is not effective by this route of administration.

  For additional information, see the accompanying leaflet entitled Living a Full Life withAsthma.

  Cromolyn Sodium Therapy in Relation to Other Treatments for Asthma: Non-steroidal agents: Cromolyn sodium inhalation solution should be added to the patient’s existing treatment regimen (e.g., bronchodilators). When a clinical response to cromolyn sodium is evident, usually within two to four weeks, and if the asthma is under good control, an attempt may be made to decrease concomitant medication usage gradually.

  If concomitant medications are eliminated or required on no more than a prn basis, the frequency of administration of cromolyn sodium inhalation solution may be titrated downward to the lowest level consistent with the desired effect. The usual decrease is from four to three ampules per day. It is important that the dosage be reduced gradually to avoid exacerbation of asthma. It is emphasized that in patients whose dosage has been titrated to fewer than four ampules per day, an increase in the dose of cromolyn sodium and the introduction of, or increase in, symptomatic medications may be needed if the patient’s clinical condition deteriorates.

  Corticosteroids: In patients chronically receiving corticosteroids for the management of bronchial asthma, the dosage should be maintained following the introduction of cromolyn sodium inhalation solution. If the patient improves, an attempt to decrease corticosteroids should be made. Even if the corticosteroid-dependent patient fails to show symptomatic improvement following cromolyn sodium administration, the potential to reduce corticosteroids may nonetheless be present. Thus, gradual tapering of corticosteroid dosage may be attempted. It is important that the dose be reduced slowly, maintaining close supervision of the patient to avoid an exacerbation of asthma.

  It should be borne in mind that prolonged corticosteroid therapy frequently causes an impairment in the activity of the hypothalamic-pituitary-adrenal axis and a reduction in the size of the adrenal cortex. A potentially critical degree of impairment or insufficiency may persist asymptomatically for some time even after gradual discontinuation of adrenocortical steroids. Therefore, if a patient is subjected to significant stress, such as a severe asthmatic attack, surgery, trauma, or severe illness while being treated or within one year (occasionally up to two years) after corticosteroid treatment has been terminated, consideration should be given to reinstituting corticosteroid therapy. When respiratory function is impaired, as may occur in severe exacerbation of asthma, a temporary increase in the amount of corticosteroids may be required to regain control of the patient’s asthma.

  It is particularly important that great care be exercised if, for any reason, cromolyn sodium inhalation solution is withdrawn in cases where its use has permitted a reduction in the maintenance dose of corticosteroids. In such cases, continued close supervision of the patient is essential since there may be sudden reappearance of severe manifestations of asthma which will require immediate therapy and possible reintroduction of corticosteroids.

  Close
  No Recall

  More Info
• Prasco Laboratories
  

  ×

  Cromolyn Sodium Solution | Prasco Laboratories

  

  ---

  NOT FOR INHALATION OR INJECTION. SEE DIRECTIONS FOR USE.

  The usual starting dose is as follows:

  Adults and Adolescents (13 Years and Older):

  Two ampules four times daily, taken one-half hour before meals and at bedtime.

  Children 2-12 Years:

  One ampule four times daily, taken one-half hour before meals and at bedtime.

  Pediatric Patients Under 2 Years:

  Not recommended.

  If satisfactory control of symptoms is not achieved within two to three weeks, the dosage may be increased but should not exceed 40 mg/kg/day.

  Patients should be advised that the effect of Cromolyn Sodium, USP therapy is dependent upon its administration at regular intervals, as directed.

  Maintenance Dose:

  Once a therapeutic response has been achieved, the dose may be reduced to the minimum required to maintain the patient with a lower degree of symptomatology. To prevent relapses, the dosage should be maintained.

  Administration:

  Cromolyn Sodium, USP should be administered as a solution at least 1/2 hour before meals and at bedtime after preparation according to the following directions:

      1. Break open ampule(s) and squeeze liquid contents of ampule(s) into a glass of water.
      2. Stir solution.
      3. Drink all of the liquid.

  Close
  No Recall

  More Info
• Pack Pharmaceuticals, Llc
  

  ×

  Cromolyn Sodium Solution | Pack Pharmaceuticals, Llc

  

  ---

  NOT FOR INHALATION OR INJECTION. SEE DIRECTIONS FOR USE.

  The usual starting dose is as follows:

  Adults and Adolescents (13 Years and Older): Two ampules four times daily, taken one-half hour before meals and at bedtime.

  Children 2-12 Years: One ampule four times daily, taken one-half hour before meals and at bedtime.

  Pediatric Patients Under 2 Years: Not recommended.

  If satisfactory control of symptoms is not achieved within two to three weeks, the dosage may be increased but should not exceed 40 mg/kg/day. Patients should be advised that the effect of Cromolyn Sodium Oral Solution, Concentrate therapy is dependent upon its administration at regular intervals, as directed.

  Maintenance Dose:

  Once a therapeutic response has been achieved, the dose may be reduced to the minimum required to maintain the patient with a lower degree of symptomatology. To prevent relapses, the dosage should be maintained.

  Administration:

  Cromolyn Sodium Oral Solution, Concentrate should be administered as a solution at least 1/2 hour before meals and at bedtime after preparation according to the following directions:

  Break open ampule(s) and squeeze liquid contents of ampule(s) into a glass of water. Stir solution. Drink all of the liquid.

  Close
  No Recall

  More Info
• Ivax Pharmaceuticals, Inc.
  

  ×

  Cromolyn Sodium Solution | Ivax Pharmaceuticals, Inc.

  

  ---

  For management of bronchial asthma in adults and pediatric patients (two years of age and over), the usual starting dosage is the contents of one vial administered by nebulization four times a day at regular intervals.

  Drug stability and safety of cromolyn sodium inhalation solution when mixed with other drugs in a nebulizer have not been established.

  Patients with chronic asthma should be advised that the effect of cromolyn sodium inhalation solution, USP therapy is dependent upon its administration at regular intervals, as directed. Cromolyn sodium inhalation solution, USP should be introduced into the patient's therapeutic regimen when the acute episode has been controlled, the airway has been cleared and the patient is able to inhale adequately.

  For the prevention of acute bronchospasm which follows exercise or exposure to cold dry air, environmental agents (e.g., animal danders, toluene diisocyanate, pollutants), etc., the usual dose is the contents of one vial administered by nebulization shortly before exposure to the precipitating factor.

  It should be emphasized to the patient that the drug is poorly absorbed when swallowed and is not effective by this route of administration.

  For additional information, see the accompanying leaflet entitled"Living a Full Life with Asthma".

  Cromolyn Sodium Inhalation Solution, USP Therapy in Relation to Other Treatments for Asthma Non-steroidal agents

  Cromolyn sodium inhalation solution, USP should be added to the patient's existing treatment regimen (e.g., bronchodilators). When a clinical response to cromolyn sodium inhalation solution, USP is evident, usually within two to four weeks, and if the asthma is under good control, an attempt may be made to decrease concomitant medication usage gradually.

  If concomitant medications are eliminated or required on no more than a prn basis, the frequency of administration of cromolyn sodium inhalation solution, USP may be titrated downward to the lowest level consistent with the desired effect. The usual decrease is from four to three vials per day. It is important that the dosage be reduced gradually to avoid exacerbation of asthma. It is emphasized that in patients whose dosage has been titrated to fewer than four vials per day, an increase in the dose of cromolyn sodium inhalation solution, USP and the introduction of, or increase in, symptomatic medications may be needed if the patient's clinical condition deteriorates.

  Corticosteroids

  In patients chronically receiving corticosteroids for the management of bronchial asthma, the dosage should be maintained following the introduction of cromolyn sodium inhalation solution, USP. If the patient improves, an attempt to decrease corticosteroids should be made. Even if the corticosteroid-dependent patient fails to show symptomatic improvement following cromolyn sodium inhalation solution, USP administration, the potential to reduce corticosteroids may nonetheless be present. Thus, gradual tapering of corticosteroid dosage may be attempted. It is important that the dose be reduced slowly, maintaining close supervision of the patient to avoid an exacerbation of asthma.

  It should be borne in mind that prolonged corticosteroid therapy frequently causes an impairment in the activity of the hypothalamic-pituitary-adrenal axis and a reduction in the size of the adrenal cortex. A potentially critical degree of impairment or insufficiency may persist asymptomatically for some time even after gradual discontinuation of adrenocortical steroids. Therefore, if a patient is subjected to significant stress, such as a severe asthmatic attack, surgery, trauma or severe illness while being treated or within one year (occasionally up to two years) after corticosteroid treatment has been terminated, consideration should be given to reinstituting corticosteroid therapy. When respiratory function is impaired, as may occur in severe exacerbation of asthma, a temporary increase in the amount of corticosteroids may be required to regain control of the patient's asthma.

  It is particularly important that great care be exercised if, for any reason, cromolyn sodium inhalation solution, USP is withdrawn in cases where its use has permitted a reduction in the maintenance dose of corticosteroids. In such cases, continued close supervision of the patient is essential since there may be sudden reappearance of severe manifestations of asthma which will require immediate therapy and possible reintroduction of corticosteroids.

  Close
  No Recall

  More Info
• Micro Labs Limited
  

  ×

  Cromolyn Sodium Solution | Micro Labs Limited

  

  ---

  
  

  NOT FOR INHALATION OR INJECTION. SEE DIRECTIONS FOR USE. 
  
  The usual starting dose is as follows:
  
  Adults and Adolescents (13 Years and Older): Two ampules four times daily, taken one-half hour before meals and at bedtime.
  
  Children 2 to 12 Years:  One ampule four times daily, taken one-half hour before meals and at bedtime.
  
  Pediatric Patients Under 2 Years: Not recommended.
  
  If satisfactory control of symptoms is not achieved within two to three weeks, the dosage may be increased but should not exceed 40 mg/kg/day. 
  
  Patients should be advised that the effect of Cromolyn Sodium Oral Solution (Concentrate)     100 mg/5 mL therapy is dependent upon its administration at regular intervals, as directed.
  
  Maintenance Dose: Once a therapeutic response has been achieved, the dose may be reduced to the minimum required to maintain the patient with a lower degree of symptomatology. To prevent relapses, the dosage should be maintained. 
  
  Administration: Cromolyn Sodium Oral Solution (Concentrate) 100 mg/5 mL should be administered as a solution at least ½ hour before meals and at bedtime after preparation according to the following directions:
  
  1.      Break open ampule(s) and squeeze liquid contents of ampule(s) into a glass of water.
  2.      Stir solution.
  3.   Drink all of the liquid.

  Close
  No Recall

  More Info